The treatment of hypertension in patients with erectile dysfunction

被引:25
|
作者
Mikhailidis, DP
Khan, MA
Milionis, HJ
Morgan, RJ
机构
[1] UCL Royal Free & Univ Coll Med Sch, Dept Mol Pathol & Clin Biochem, London NW3 2QG, England
[2] UCL Royal Free & Univ Coll Med Sch, Dept Urol, London NW3 2QG, England
关键词
beta-blockers; diuretics; doxazosin; erectile dysfunction; hypertension;
D O I
10.1185/0300799009117037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension is another predictor of erectile dysfunction (ED). This is further evidence supporting a link between the pathogenesis of atherosclerotic disease ann ED. In one study (TOMHS) involving hypertensive patients, the incidence of ED was 14.4%. The drugs used to treat hypertension may cause ED. However, there is little trial-based evidence to indicate which drugs are more likely to cause this side effect. In general, thiazide diuretics and beta-blockers seem to cause ED more often. In contrast, the alpha-blocker doxazosin, has Mot been associated with an increased incidence of ED as a sine effect. Doxazosin also improves urinary flow in patients with benign prostatic hyperplasia (BPH). This condition is common in elderly men as is hypertension and ED. Therefore, doxazosin may present a special advantage among this group of patients. This alpha-blocker would also be a good choice in patients with impaired glucose tolerance/diabetes because it improves insulin sensitivity. Moreover, ED and hypertension are more prevalent among diabetics. On a more speculative note, doxazosin may potentiate the therapeutic impact of specific treatments for ED.
引用
收藏
页码:S31 / S36
页数:6
相关论文
共 50 条
  • [1] Erectile dysfunction in patients with hypertension
    de León, AJC
    García, VR
    González, JCC
    Hoyos, SP
    Multó, FB
    MEDICINA CLINICA, 2002, 119 (14): : 521 - 526
  • [2] Use of Impaza in the Treatment of Erectile Dysfunction in Patients with Essential Hypertension and CHD
    Neimark, A. I.
    Aliev, R. T.
    Muzalevskaya, N. I.
    Krainichenko, S. V.
    Vorob'eva, E. N.
    Tarasova, T. S.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2009, 148 (02) : 328 - 331
  • [3] Treatment of erectile dysfunction in patients with essential hypertension and ischemic heart disease
    Neimark, A. L.
    Aliev, R. T.
    Muzalevskaya, N. L.
    Krainichenko, S. V.
    Vorobyeva, E. N.
    Tarasova, T. S.
    TERAPEVTICHESKII ARKHIV, 2008, 80 (04) : 60 - 63
  • [4] Use of Impaza in the Treatment of Erectile Dysfunction in Patients with Essential Hypertension and CHD
    A. I. Neimark
    R. T. Aliev
    N. I. Muzalevskaya
    S. V. Krainichenko
    E. N. Vorob’eva
    T. S. Tarasova
    Bulletin of Experimental Biology and Medicine, 2009, 148
  • [5] Deterniinants of erectile dysfunction in patients with essential hypertension
    Doumas, M
    Tsakiris, A
    Douma, S
    Hounta, A
    Papadopoulos, A
    Tsiodras, S
    Paraskeuakou, G
    Antoniou, V
    Giamarellou, H
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 143A - 143A
  • [6] Erectile dysfunction and hypertension
    Jackson, G
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (07) : 491 - +
  • [7] Hypertension and erectile dysfunction
    Gidaro B.
    Lonati C.
    Garagiola M.
    Periti E.
    Morganti A.
    High Blood Pressure & Cardiovascular Prevention, 2006, 13 (1) : 7 - 11
  • [8] Hypertension and erectile dysfunction
    Bueno Brandao, Sergio Augusto
    Silva, Renato de Oliveira e
    de Oliveira Izar, Maria Cristina
    Helfenstein, Tatiana
    de Castro Monteiro, Carlos Manoel
    Santos, Andreza Oliveira
    Matheus Fischer, Simone Cristina Pinto
    Helfenstein Fonseca, Francisco Antonio
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (03) : 5 - 5
  • [9] Erectile dysfunction and hypertension
    R Kloner
    International Journal of Impotence Research, 2007, 19 : 296 - 302
  • [10] Erectile dysfunction and hypertension
    Kloner, R.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2007, 19 (03) : 296 - 302